Clinical Trials

    Showing 1 - 6 of 6 Coronary Artery Disease

    CoreValve® Expanded

    Status: Open Not Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Deena Victor

    Phone: 713.441.4536

    The primary objective of the study is to evaluate the safety and effectiveness of the Medtronic CoreValve® System (MCS) in a subset of subjects excluded from the U.S. Extreme Risk Pivotal Trial population due to one or more additional co-morbidities,... Read more >

    Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II (COSIRA-II)

    Status: Enrolling

    Investigator: Alpesh Shah

    Study Coordinator: Padmaja Naik

    Phone: 713.441.7386

    To demonstrate the safety and effectiveness of the Reducer system for treatment of patients with refractory angina pectoris treated with maximally tolerated guideline-directed medical therapy who demonstrate objective evidence of reversible myocardia... Read more >

    FAME 3

    Status: Open Not Enrolling

    Investigator: Alpesh Shah

    Study Coordinator: Iris Alanis

    Phone: 713.441.6548

    The purpose of this study is to determine whether Fractional flow reserve (FFR, (coronary pressure wire-based index for assessing the ischemic potential of a coronary lesion)-guided percutaneous coronary intervention (PCI) in patients with multivesse... Read more >

    NCT06122246

    Status: Enrolling

    Investigator: Khurram Nasir

    Study Coordinator: Zulqarnain Javed

    Phone: 346.356.1481

    In this comparative effectiveness trial, the aim of this study is to answer the research question of whether a remote blood pressure (BP) management program (RBPM, inclusive of home BP monitoring and telehealth visits with a nurse or pharmacist) alon... Read more >

    SURTAVI

    Status: Open Not Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Tia McGaughy

    Phone: 346.238.4576

    The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgical Ao... Read more >

    The JenaValve ALIGN-AR Pivotal Trial (ALIGN-AR)

    Status: Enrolling

    Investigator: Michael Reardon

    Study Coordinator: Yejide Oyewole

    Phone: 346.238.2294

    Brief Summary: To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allow... Read more >